- Home
- CMND vs VCIG Comparison
CMND vs VCIG Comparison
Compare CMND & VCIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CMND | VCIG |
|---|---|---|
| Founded | 2017 | 2013 |
| Country | Canada | Malaysia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6M | 2.9M |
| IPO Year | 2021 | 2022 |
Fundamental Metrics
Financial Performance| Metric | CMND | VCIG |
|---|---|---|
| Price | $2.93 | $7.40 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 2.7M | ★ 5.4M |
| Earning Date | 03-12-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1.81 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.07 | $0.20 |
| 52 Week High | $4.66 | $23.40 |
Technical Indicators
Market Signals| Indicator | CMND | VCIG |
|---|---|---|
| Relative Strength Index (RSI) | 69.38 | 83.99 |
| Support Level | $0.31 | $0.69 |
| Resistance Level | N/A | $15.45 |
| Average True Range (ATR) | 0.33 | 1.36 |
| MACD | 0.25 | 0.81 |
| Stochastic Oscillator | 61.26 | 62.93 |
Price Performance
Historical ComparisonAbout CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.
About VCIG VCI Global Limited
VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology development, solutions and consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment, which focuses on listing solutions, investor relations, and boardroom strategies consultancy.